Search Browse Earnings

biote Corp.

Nasdaq:BTMD

Medicinal Chemicals & Botanical Products·IRVING, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

biote Corp. — SlamSEC

Revenue

$197.2M

+6.4% YoY

FY 2025

Adj. EBITDA

$35.2M

17.8% margin

FY 2025

Net Income

$3.2M

1.6% margin

FY 2025

EPS (Diluted)

$0.09

FY 2025

Stock Price

$1.40

2026-03-13

52W Range

—

P/E Ratio

15.6x

Market Cap

—

Cash

$39.3M

FY 2025

Total Debt

$101.3M

FY 2025

Net Debt

$62.0M

FY 2025

Enterprise Value

—

Debt / EBITDA

1.8x

FY 2025

EV / EBITDA

—

Employees

—